Stifel analyst Alex Thompson reiterated a Buy rating and $52.00 price target on Dianthus Therapeutics (NASDAQ: DNTH)The analyst comments "We ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments

Dianthus Therapeutics (DNTH) Misses Q4 EPS by 81cMarch 12, 2025 6:33 AM Form S-8 Dianthus Therapeutics, March 11, 2025 4:10 PM Form 10-K Dianthus Therapeutics, For: Dec 31March 11, 2025 4:07 PM Form 8-K Dianthus Therapeutics, For: Mar 11March 11, 2025 4:04 PM Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q4 and FY 2024 Financial ResultsMarch 11, 2025 4:01 PM